DE602005008076D1 - Verfahren zur herstellung von rosiglitazon - Google Patents

Verfahren zur herstellung von rosiglitazon

Info

Publication number
DE602005008076D1
DE602005008076D1 DE602005008076T DE602005008076T DE602005008076D1 DE 602005008076 D1 DE602005008076 D1 DE 602005008076D1 DE 602005008076 T DE602005008076 T DE 602005008076T DE 602005008076 T DE602005008076 T DE 602005008076T DE 602005008076 D1 DE602005008076 D1 DE 602005008076D1
Authority
DE
Germany
Prior art keywords
rosiglitazone
preparation
formula
reduction
yridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005008076T
Other languages
English (en)
Inventor
Ales Halama
Petr Lustig
Josef Jirman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva KS
Original Assignee
Zentiva KS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva KS filed Critical Zentiva KS
Publication of DE602005008076D1 publication Critical patent/DE602005008076D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE602005008076T 2004-09-10 2005-08-31 Verfahren zur herstellung von rosiglitazon Expired - Fee Related DE602005008076D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20040956A CZ297266B6 (cs) 2004-09-10 2004-09-10 Zpusob prípravy rosiglitazonu
PCT/CZ2005/000067 WO2006026934A1 (en) 2004-09-10 2005-08-31 Method for the preparation of rosiglitazone

Publications (1)

Publication Number Publication Date
DE602005008076D1 true DE602005008076D1 (de) 2008-08-21

Family

ID=35520549

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005008076T Expired - Fee Related DE602005008076D1 (de) 2004-09-10 2005-08-31 Verfahren zur herstellung von rosiglitazon

Country Status (6)

Country Link
EP (1) EP1786808B1 (de)
AT (1) ATE400572T1 (de)
CZ (1) CZ297266B6 (de)
DE (1) DE602005008076D1 (de)
EA (1) EA200700568A1 (de)
WO (1) WO2006026934A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1887006A1 (de) * 2006-08-07 2008-02-13 Krka Polymorphe Formen von Rosiglitazon- Base

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (de) * 1987-09-04 1998-05-20 Beecham Group Plc Substituierte Thiazolidindionderivate
US5585495A (en) * 1991-12-20 1996-12-17 The Upjohn Company Reduction method for substituted 5-methylene-thiazolidinediones
UY24886A1 (es) * 1997-02-18 2001-08-27 Smithkline Beecham Plc Tiazolidindiona
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
WO2003029251A1 (en) * 2001-09-28 2003-04-10 Biocon Limited Novel process for the synthesis of thiazolidinedione derivatives
WO2004007490A2 (en) * 2002-07-16 2004-01-22 Cadila Healthcare Limited A process to prepare pioglitazone via several intermediates.
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (de) * 2004-01-28 2006-10-11 Usv Limited Verfahren zur herstellung von 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]phenylmethyl]thiazolidin-2,4-dionmaleat

Also Published As

Publication number Publication date
ATE400572T1 (de) 2008-07-15
WO2006026934A1 (en) 2006-03-16
EA200700568A1 (ru) 2007-08-31
CZ2004956A3 (cs) 2006-04-12
EP1786808A1 (de) 2007-05-23
EP1786808B1 (de) 2008-07-09
CZ297266B6 (cs) 2006-10-11

Similar Documents

Publication Publication Date Title
WO2005080358A3 (en) Rosiglitazone phosphate and polymorphic forms
CY1107238T1 (el) Παρασκευη μιας πολυμορφικης μορφης ενος παραγωγου θειαζολιδινοδιονης
CO6160231A2 (es) Compuestos de isoindolina 5-substituidos
TW200738136A (en) Fungicidal N-[2-(haloalkoxy)phenyl]heteroarylcarboxamides
DZ3316A1 (de) Hcl-salze von 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dion
ATE445397T1 (de) N-hydroxy-4-ä5-ä4-(5-isopropyl-2-methyl-1,3- thiazol-4-yl)phenoxyüpentoxyübenzamidin 2 methansulfonsauresalz
EA200701680A1 (ru) Лекарственная форма для перорального введения, содержащая розиглитазон
ATE246191T1 (de) Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz
MXPA03002580A (es) Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
DE602005008076D1 (de) Verfahren zur herstellung von rosiglitazon
GB0410013D0 (en) Process
EA200300345A1 (ru) Гидрохлоридная соль 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона
YU16303A (sh) Tartaratne soli derivata tiazolidindiona
ATE488515T1 (de) Rosiglitazonhydrochlorid-hemihydrat
WO2005021542A3 (en) Process for the preparation of pioglitazone
DE60115062D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
ATE329914T1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
ATE343574T1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
EA200700003A1 (ru) Соль фосфорной кислоты и 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона и способ её получения
AU2003269483A1 (en) Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione
WO2008010089A3 (en) Process for preparation of intermediates of rosiglitazone, rosiglitazone and polymorphic forms thereof
NO20092362L (no) 2-N-(5-[{4-(2-(metyl-2-pyridinylamino) etoksy] fenyl]metyl}2,4-tiazolidinedion) butanedisyre, fremgangsmater for fremstilling og sammensetninger med rosiglitazon maleat
DE602004015784D1 (de) Verkapselte materialien
EA200700206A1 (ru) Соль щавелевой кислоты с 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-дионом, способ её получения и применение

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee